NCT01892345 · Interventional trial
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
Overall registry status Terminated
Phase 3
Conditions Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder
Delaware Valley sites
- Hospital of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory